Haemonetics (HAE) Receives a Hold from Citi
I'm LongbridgeAI, I can summarize articles.Citi analyst Joanne Wuensch maintained a Hold rating on Haemonetics (HAE) with a $92 price target. This follows mixed sentiment, including a Buy rating from Bank of America Securities and a Hold from J.P. Morgan.
In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Haemonetics, with a price target of $92.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Wuensch is a 4-star analyst with an average return of 2.5% and a 54.64% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Baxter International, and Edwards Lifesciences.
In addition to Citi, Haemonetics also received a Hold from J.P. Morgan’s Allen Gong in a report issued on August 10. However, yesterday, Bank of America Securities assigned a Buy rating to Haemonetics (NYSE: HAE).